Lupin launches generic Sugammadex injection in US
- Source
- The Economic Times - Industry
- Source link
- https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-launches-generic-sugammadex-injection-in-us/articleshow/132761291.cms
- Published
- 2026-07-31 08:33:18
- Discovered by ProcIntel
- 2026-07-31 08:54:55
- Category
- Procurement & Supply Chain News
- Geography
- India
- Organisations
- —
- Review status
- Pending
- Record type
- REAL
Summary
Lupin Limited announced the launch of its Sugammadex Injection in the United States. This follows approval from the US Food and Drug Administration for its abbreviated new drug application. The company's injection is claimed to be bioequivalent to Merck's Bridion Injection. It is indicated for reversing neuromuscular blockade in adult and pediatric surgical patients. The launch occurred on Friday, as per a regulatory filing.
Procurement Relevance Gate
FAIL
— score 7.0/100 — evaluated 2026-07-31 08:55:19
Only geographic exposure matched — no substantive content indicator, so this cannot pass alone.
- geographic_exposure (weight 8) — matched on "1 linked geography"
Initial Signal Assessment ProcIntel's automatic, provisional read of this individual Signal -- Initial Significance and Initial Confidence, computed deterministically before any Event extraction or human review.
A provisional, automatically-computed reading of this individual Signal, before Event extraction or human review. Not a final rating.
Not Assessed — this Signal did not pass the Procurement Relevance Gate, or is fictional/excluded test data.